Medical Devices
Japan Biomaterials in Healthcare Market Analysis
The Japan Biomaterials Healthcare Market is expected to witness growth from $9.71 Bn in 2022 to $27.12 Bn in 2030 with a CAGR of 13.70% for the forecasted year 2022-2030. In Japan, the prevalence of illnesses like gingivitis, tooth decay, oral cancer, halitosis, and dental caries is increasing, which is fueling demand for biomaterials and boosting the country's biomaterial healthcare market. The market is segmented by type and by application. Some key players in this market include: Terumo, Asahi Kasei Corporation, Menicon, BASF SE, Johnson and Johnson, Medtronic and Evonik Industries.
Buy Now
Japan Biomaterials in Healthcare Market Executive Analysis
The Japan Biomaterials Healthcare Market size is at around $9.71 Bn in 2022 and is projected to reach $27.12 Bn in 2030, exhibiting a CAGR of 13.70% during the forecast period. From $4,256 in 2018, when it represented 10.75% of GDP, to $4,360 in 2019, when it would reflect 10.74% of GDP, the amount spent on healthcare per person in Japan has increased significantly. The country has a sophisticated and technologically cutting-edge healthcare infrastructure as a result of its high healthcare expenditure. In 2022, there were 12.7 deaths per 1,000 people in Japan. Cancer is the cause of 29% of deaths in Japan.
Japan's biomaterials healthcare market is a quickly expanding industry with the ability to completely transform the country's healthcare system. Synthetic or organic materials known as biomaterials are used to replace or treat diseased or damaged tissues and systems. Numerous medicinal fields, including orthopaedics, cardiology, dentistry, and tissue engineering, use these materials. In orthopaedic surgeries, biomaterials are frequently used to substitute or repair damaged joints, bones, and tissues. In hip, knee, and spinal prostheses, materials like titanium, cobalt-chromium, and polyethylene are frequently used. Heart valves, stents, and pacemakers are all cardiovascular devices that make use of biomaterials. These materials, which are frequently made of ceramics, polymers, or metals, are intended to work with the body's natural cells.
Dental implants use biomaterials to substitute missing teeth or restore teeth that have been damaged. Dental implants frequently consist of materials like titanium, zirconia, and ceramic. By being compatible with the body's native tissues, biomaterials lower the possibility of rejection or negative reactions. Since biomaterials are frequently more resilient than native tissues, implants can last longer and require fewer procedures overall. Biomaterials can speed up the body's natural healing processes, shortening healing periods, and enhance results. Treatment precision and efficacy can be increased by using biomaterials that can be tailored to each patient's unique requirements.
Market Dynamics
Market Growth Drivers
In Japan, the prevalence of illnesses like gingivitis, tooth decay, oral cancer, halitosis, and dental caries is increasing, which is fueling demand for biomaterials and boosting the country's biomaterial healthcare market. Examples of biomaterials include metals, polymers, ceramics, and composites. More people are becoming aware of the advantages of using nanomaterials in medicine, including patients and healthcare workers. Without a question, demand will increase as more people become aware of these things. As Japan's population ages, there is a growing demand for biomaterials to treat conditions like osteoarthritis, spine issues, and cardiovascular disease. The Japanese government is committed to promoting the growth of the biofuels industry. This includes grants for research and development, tax breaks, and regulatory assistance, all of which help the Japanese biomaterial healthcare market progress and expand.
Market Restraints
In Japan, the supply of raw materials used to make biomaterials can be constrained, especially for uncommon and specialised materials. Manufacturers may find it challenging to increase output to keep up with demand as a result. The healthcare biomaterials market is extremely competitive, and there are already many well-established companies with significant market share and brand recognition. This can make it difficult for new competitors to find success in the industry.
Competitive Landscape
Key Players
- Terumo (JP)
- Asahi Kasei Corporation (JP)
- Menicon (JP)
- BASF SE
- Johnson and Johnson
- Medtronic
- Evonik Industries
Notable Recent Deals
2023: Vaupell Holdings, Inc., a US-based business that specialises in designing and producing high-performance plastic components for the aerospace, medical, and commercial sectors, has been acquired by Sumitomo Bakelite Co. Ltd. The purchase will increase Sumitomo Bakelite's market share in the Japanese healthcare biomaterials industry.
Healthcare Policies and Regulatory Landscape
The Pharmaceuticals and Medical Devices Agency (PMDA) is the primary regulatory agency in charge of regulating the Japanese biomaterials healthcare market. The PMDA is in charge of examining and authorising pharmaceuticals, regenerative medicine products, medical devices, and biomaterials. The Ministry of Health, Labor, and Welfare (MHLW), in addition to PMDA, is crucial to the regulation of the Japanese biomaterials healthcare industry. The MHLW is in charge of establishing requirements for the quality and security of pharmaceuticals, regenerative medicine goods, and medical devices, including biomaterials. The Act on the Safety of Regenerative Medicine is one of the main laws governing the use of biomaterials in healthcare in Japan. This law lays out the rules for the creation and marketing of goods for regenerative medicine, including biomaterials. Before goods are approved for use in patients, the act requires manufacturers to present proof of their products' efficacy and safety. The Good Manufacturing Practice (GMP) regulations are a crucial policy in Japan's biomaterials healthcare industry. These recommendations lay out the quality assurance and control requirements that producers of pharmaceuticals, medical equipment, and biomaterials, among other things, must adhere to.
1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
Biomaterials in Healthcare Market Segmentation
By Type (Revenue, USD Billion):
Based on type, the market is segmented into Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, and Natural Biomaterials. The Metallic Biomaterials segment accounted for the largest share of the Japan market in 2019. The growing geriatric population Japanly is expected to drive growth for this segment.
- Metallic Biomaterials
- Stainless Steel
- Titanium & Titanium Alloys
- Cobalt-Chrome Alloys
- Gold
- Silver
- Magnesium
- Polymeric Biomaterials
- Polymethylmethacrylate
- Polyethylene
- Polyester
- Silicone Rubber
- Nylon
- Polyetheretherketone
- Other Polymeric Biomaterials
- Ceramics
- Calcium Phosphate
- Zirconia
- Aluminum Oxide
- Calcium Sulfate
- Carbon
- Glass
- Natural Biomaterials
- Hyaluronic Acid
- Collagen
- Gelatin
- Fibrin
- Cellulose
- Chitin
- Alginates
- Silk
By Application (Revenue, USD Billion):
The cardiovascular, orthopaedic, dental, plastic surgery, wound healing, tissue engineering, ophthalmology, neurological/CNS, and other applications segments are made up of the biomaterials market. The market category for wound healing is anticipated to have the highest CAGR in 2019. The market will increase as a result of factors including expanding healthcare infrastructure, a large population pool, a rising diabetic population, and rising healthcare spending. Surgical Guides
- Cardiovascular
- Catheters
- Stents
- Implantable Cardiac Defibrillators
- Pacemakers
- Sensors
- Heart Valves
- Vascular Grafts
- Guidewires
- Others
- Orthopedic
- Joint Replacement
- Knee Replacement
- Hip Replacement
- Shoulder Replacement
- Others
- Viscosupplementation
- Bioresorbable Tissue Fixation
- Spine?
- Spinal Fusion Surgeries
- Minimally Invasive Fusion Surgeries
- Motion Preservation & Dynamic Stabilization Surgeries
- Pedicle-Based Rod Systems
- Interspinous Spacers
- Artificial Discs
- Fracture Fixation Devices
- Bone Plates
- Screws
- Pins
- Rods
- Wires
- Synthetics Bone Grafts
- Joint Replacement
- Ophthalmology
- Contact Lenses
- Intraocular Lenses
- Functional Replacement of Ocular Tissues
- Synthetic Corneas
- Others
- Contact Lenses
- Dental
- Dental Implants
- Dental Bone Grafts & Substitutes
- Dental Membranes
- Tissue Regeneration
- Plastic Surgery
- Soft-Tissue Fillers
- Craniofacial Surgery
- Wound Healing
- Wound Closure Devices
- Sutures
- Staples
- Surgical Hemostats
- Internal Tissue Sealants
- Adhesion Barriers
- Hernia Meshes
- Wound Closure Devices
- Tissue Engineering
- Scaffolds for Regenerative Medicine
- Nanomaterials for Biosensing
- Tailoring of Inorganic Nanoparticles
?
- Neurological/Central Nervous System Applications
- Shunting Systems
- Cortical Neural Prosthetics
- Hydrogel Scaffolds for CNS Repair
- Neural Stem Cell Encapsulation
?
- Other Applications
- Drug Delivery Systems
- Gastrointestinal Applications
- Bariatric Surgery
- Urinary Applications
Insights10 will provide you with the reports within 10 key parameters which are:
- Market Overview
- Market Growth Drivers & Restraints
- Epidemiology of Disease Type
- Market Segmentation
- Market Share
- Competitive Landscape
- Key Company Profiles
- Healthcare Policies & Regulatory Framework
- Reimbursement Scenario
- Factors Driving Future Growth
Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.
Stage I: Market Data Collection
Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.
Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.
Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:
Stage II: Market Data Analysis and Statistical Model
Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.
Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.
The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.
The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.
Data Triangulation & Validation:
Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.
We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.
(1).png)
Stage III: Interpretation and Presentation
Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)
- Establishing market drivers and trends
- Analyzing the regulatory landscape to understand future growth
- Market Segment based analysis to obtain revenue/volume
- Analyzing current needs and determining penetration to estimate the market
Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.
Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.
To request a free sample copy of this report, please complete the form below.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
This report addresses
- Intelligent insights to take informed business decisions
- Qualitative, acute and result oriented market analysis
- Market size and forecasts from 2022 to 2030
- Opportunities for expansion and in-depth market analysis
- Segmentation and regional revenue forecasts
- Analysis of the market share and competitive landscape
- Strategic Recommendations to chart future course of action
- Comprehensive Market Research Report in PDF and PPT formats
Need more?
- Ask our analyst how this study was put together to learn more
- Discuss additional requirements as part of the free customisation
- Add more countries or regions to the scope
- Get answers to specific business questions
- Develop the business case to launch the product
- Find out how this report may influence your business revenue
Related reports (by category)
Medical Devices
Romania ENT Devices Market Analysis
Medical Devices
Singapore Biomaterials in Healthcare Market Analysis
Medical Devices
Ireland ENT Devices Market Analysis
Related reports (by geography)
Pharmaceuticals
Japan End-stage Renal Disease(ESRD) Market Analysis
Pharmaceuticals
Japan Pigments Market Analysis
Rare Diseases